My sibling was just diagnosed — do I need to be tested for Wilson disease?

Yes, you should be tested, and sooner rather than later. “Feeling fine” is not reassuring in this context, because Wilson disease is notorious for silently accumulating copper for years — sometimes more than a decade — before any symptom appears.¹ By the time symptoms do appear, organ damage is often already present. Testing you now, while you feel well, is the whole point.

Both the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL) explicitly recommend that all first-degree relatives of a diagnosed patient be evaluated as soon as possible after the index diagnosis.²³ A sibling is the closest category of relative — you and your sibling share the same parents, which means you both had the same chance of inheriting a faulty copy of the ATP7B gene from each parent.

What your actual risk is

Wilson disease is autosomal recessive. To develop the condition, a person must inherit one faulty ATP7B copy from each parent.¹ Since your sibling has the disease, both of your parents are carriers (each carrying one faulty copy). That means every child they had — including you — faced a:

Outcome	Probability
Wilson disease (two faulty copies)	25%
Carrier, no disease (one faulty copy)	50%
Unaffected, not a carrier	25%

A one-in-four chance is not rare. It is why the guidelines use the word “should” rather than “may consider” when recommending sibling screening.²

What the testing involves

Evaluation typically combines two complementary approaches:

Genetic testing is now the most efficient first step. Your sibling’s ATP7B mutations are already known from their diagnosis. A blood test checks whether you carry the same variants. This is fast, definitive, and has become the preferred starting point for family screening in clinical practice.² A single blood draw is usually all that is needed.

Biochemical testing is added alongside genetic testing — or used when genetic results are inconclusive — and includes:

• Serum ceruloplasmin (a copper-transport protein; low levels suggest copper accumulation)
• 24-hour urine copper
• Serum copper
• Slit-lamp eye examination (looking for Kayser-Fleischer rings)
• Liver enzymes and function tests

No single test is perfectly reliable on its own, which is why the combination matters.³ Your result should be interpreted by a clinician experienced in Wilson disease, not just by the normal reference ranges on a lab printout.

What happens if the test comes back positive?

If you carry two ATP7B mutations, you have Wilson disease — even with no symptoms. This is actually excellent news in one specific way: pre-symptomatic patients who begin treatment promptly can prevent organ damage almost entirely, and most go on to have normal or near-normal life spans.⁴

Treatment for pre-symptomatic Wilson disease is usually zinc salts, which block copper absorption from the gut.²³ Zinc is generally well-tolerated and can be started well before any symptoms develop. You would also begin regular monitoring — liver enzymes, urine copper, periodic slit-lamp checks — to confirm the treatment is working.

If you carry only one mutation, you are a carrier. Carriers do not develop Wilson disease and do not need treatment. However, knowing your carrier status matters for future reproductive decisions: if your partner also happens to be a carrier, there is a 25% chance with each pregnancy that a child would be affected. More detail on this is in the family screening post.

How urgent is this, really?

More urgent than most people expect. The case for speed comes from this: copper accumulation is continuous, not reversible in real time. Every month without treatment is a month of copper depositing in your liver and — eventually — your brain. The damage that accumulates is not easily undone once it is established.

The Walshe 1988 report in The Lancet on presymptomatic diagnosis described patients detected through family screening who began treatment before any clinical signs and remained entirely well on follow-up — demonstrating that catching the disease in this window changes outcomes fundamentally.⁵ More recent guidance confirms this: early identification through family screening is one of the few situations in medicine where a disease can be prevented rather than merely treated after the fact.²

Practically speaking: call your own GP today or this week and say, “My sibling was just diagnosed with Wilson disease and I need a referral to a hepatologist for evaluation.” You can also ask your sibling to share the contact details for their specialist — sometimes a Wilson disease centre can arrange screening of relatives directly.

What to expect at the appointment

Bring whatever information your sibling can share about their mutations (the specific ATP7B variants identified in their genetic test). This allows the lab to look for the exact same changes in you, making your result faster and more definitive.

If your sibling’s specialist centre has an established family screening protocol — many do — ask whether you can be seen there. A centre already familiar with your sibling’s case will have all the relevant context.

Do not wait for symptoms

The defining feature of pre-symptomatic Wilson disease is that there are no symptoms. Waiting until something feels wrong defeats the purpose of family screening. People with Wilson disease can have substantial liver copper loading for a decade before any test or symptom reveals itself.¹⁶ The genetic and biochemical testing process is straightforward; the only genuine risk is delay.

See also: how Wilson disease is diagnosed for a fuller description of the diagnostic tests.

This post is for general patient education and is not a substitute for a consultation with your doctor or specialist. Please contact your GP or hepatologist promptly.

References